Gut microbes may hold the key to cancer therapy effectiveness
Groundbreaking research reveals gut microbes and their chemical by-products significantly influence cancer treatment outcomes. A bacterial metabolite, 2-MiCit, found in tumors, effectively slows cancer growth and enhances chemotherapy by disrupting cell functions. This discovery suggests personalized oncology could leverage microbiome profiling and dietary interventions to boost therapy effectiveness, promising improved survival rates for patients.
Groundbreaking research reveals gut microbes and their chemical by-products significantly influence cancer treatment outcomes. A bacterial metabolite, 2-MiCit, found in tumors, effectively slows cancer growth and enhances chemotherapy by disrupting cell functions. This discovery suggests personalized oncology could leverage microbiome profiling and dietary interventions to boost therapy effectiveness, promising improved survival rates for patients.
